Raffles Medical Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Raffles Medical Group heeft een totaal eigen vermogen van SGD1.0B en een totale schuld van SGD74.7M, wat de schuld-eigenvermogensverhouding op 7.2% brengt. De totale activa en totale passiva bedragen respectievelijk SGD1.5B en SGD486.8M. De EBIT Raffles Medical Group is SGD72.8M waardoor de rentedekking -18.2 is. Het heeft contanten en kortetermijnbeleggingen van SGD316.3M.

Belangrijke informatie

7.2%

Verhouding schuld/eigen vermogen

S$74.70m

Schuld

Rente dekkingsratio	-18.2x
Contant	S$316.33m
Aandelen	S$1.03b
Totaal verplichtingen	S$486.82m
Totaal activa	S$1.52b

Recente financiële gezondheidsupdates

Recent updates

Raffles Medical Group (SGX:BSL) Is Reducing Its Dividend To SGD0.024

May 09

Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024

Apr 25

Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 10

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Nov 16

Raffles Medical Group (SGX:BSL) Is Doing The Right Things To Multiply Its Share Price

Nov 03

Here's Why Raffles Medical Group (SGX:BSL) Has Caught The Eye Of Investors

Aug 23

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Jul 24

Raffles Medical Group (SGX:BSL) Could Easily Take On More Debt

Jun 13

A Look At The Fair Value Of Raffles Medical Group Ltd (SGX:BSL)

May 30

Is Now The Time To Put Raffles Medical Group (SGX:BSL) On Your Watchlist?

May 12

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To SGD0.038

May 01

Raffles Medical Group (SGX:BSL) Might Have The Makings Of A Multi-Bagger

Mar 13

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Feb 14

Returns At Raffles Medical Group (SGX:BSL) Are On The Way Up

Dec 04

Do Raffles Medical Group's (SGX:BSL) Earnings Warrant Your Attention?

Nov 21

Is There An Opportunity With Raffles Medical Group Ltd's (SGX:BSL) 25% Undervaluation?

Oct 09

Is Raffles Medical Group (SGX:BSL) A Risky Investment?

Sep 26

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Sep 01

With EPS Growth And More, Raffles Medical Group (SGX:BSL) Makes An Interesting Case

Aug 20

Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Jun 01

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To S$0.028

May 02

We Think Raffles Medical Group (SGX:BSL) Can Manage Its Debt With Ease

Apr 18

Slowing Rates Of Return At Raffles Medical Group (SGX:BSL) Leave Little Room For Excitement

Feb 21

Raffles Medical Group (SGX:BSL) Seems To Use Debt Rather Sparingly

Oct 14

Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Oct 02

At S$1.40, Is Raffles Medical Group Ltd (SGX:BSL) Worth Looking At Closely?

Sep 21

Here's Why I Think Raffles Medical Group (SGX:BSL) Is An Interesting Stock

Aug 12

Here's What's Concerning About Raffles Medical Group's (SGX:BSL) Returns On Capital

Jul 01

At S$1.08, Is It Time To Put Raffles Medical Group Ltd (SGX:BSL) On Your Watch List?

May 25

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( SGD476.0M ) BSL } overtreffen de korte termijn passiva ( SGD397.1M ).

Langlopende schulden: De kortetermijnactiva BSL ( SGD476.0M ) overtreffen de langetermijnschulden ( SGD89.7M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: BSL heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van BSL is de afgelopen 5 jaar gedaald van 15% naar 7.2%.

Schuldendekking: De schuld van BSL wordt goed gedekt door de operationele kasstroom ( 130.1% ).

Rentedekking: BSL verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Balans

Ontdek gezonde bedrijven

Bedrijfsanalyse en status van financiële gegevens

Gegevens	Laatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse	2024/12/21 17:17
Aandelenkoers aan het einde van de dag	2024/12/20 00:00
Inkomsten	2024/06/30
Jaarlijkse inkomsten	2023/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

Pakket	Gegevens	Tijdframe	Voorbeeld Amerikaanse bron ^*
Financiële gegevens bedrijf	10 jaar	Resultatenrekening Kasstroomoverzicht Balans	SEC-formulier 10-K SEC-formulier 10-Q
Consensus schattingen analisten	+3 jaar	Financiële prognoses Koersdoelen analisten	Onderzoeksrapporten van analisten Blue Matrix
Marktprijzen	30 jaar	Aandelenprijzen Dividenden, splitsingen en acties	ICE Marktgegevens SEC-formulier S-1
Eigendom	10 jaar	Top aandeelhouders Handel met voorkennis	SEC-formulier 4 SEC-formulier 13D
Beheer	10 jaar	Leiderschapsteam Raad van bestuur	SEC-formulier 10-K SEC-formulier DEF 14A
Belangrijkste ontwikkelingen	10 jaar	Bedrijfsaankondigingen	SEC-formulier 8-K

^* voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige regelgevingsformulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Lees hier meer.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op .

Bronnen van analisten

Raffles Medical Group Ltd wordt gevolgd door 20 analisten. 8 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

Analist	Instelling
David Mak	CGS International
Patrick Yau	Citigroup Inc
Horng Han Low	CLSA

Raffles Medical Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Raffles Medical Group (SGX:BSL) Could Easily Take On More Debt

Is Raffles Medical Group (SGX:BSL) A Risky Investment?

We Think Raffles Medical Group (SGX:BSL) Can Manage Its Debt With Ease

Raffles Medical Group (SGX:BSL) Seems To Use Debt Rather Sparingly

Recent updates

Executive Chairman & CEO recently bought S$602k worth of stock

Executive Chairman & CEO recently bought S$861k worth of stock

Executive Chairman & CEO recently bought S$1.3m worth of stock

Executive Chairman & CEO recently bought S$979k worth of stock

Executive Chairman & CEO recently bought S$1.5m worth of stock

Executive Chairman & CEO recently bought S$700k worth of stock

New minor risk - Dividend sustainability

Executive Chairman & CEO recently bought S$1.3m worth of stock

First half 2024 earnings released: EPS: S$0.017 (vs S$0.032 in 1H 2023)

Executive Chairman & CEO recently bought S$1.5m worth of stock

Raffles Medical Group Ltd to Report First Half, 2024 Results on Jul 29, 2024

Raffles Medical Group (SGX:BSL) Is Reducing Its Dividend To SGD0.024

Executive Chairman & CEO recently bought S$500k worth of stock

Upcoming dividend of S$0.024 per share

Raffles Medical Group Ltd Approves One-Tier Tax Exempt Final Dividend for the Year Ended 31 December 2023, Payable on May 23, 2024

Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024

Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Full year 2023 earnings: EPS misses analyst expectations

Now 20% undervalued

Raffles Medical Group Ltd Proposes Final Dividend for the Year Ended 31 December 2023, Payable on May 23, 2024

Price target decreased by 12% to S$1.14

Consensus EPS estimates fall by 21%

Executive Chairman & CEO recently bought S$3.6m worth of stock

Dividend of S$0.024 announced

Raffles Medical Group Ltd, Annual General Meeting, Apr 26, 2024

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Investor sentiment deteriorates as stock falls 15%

Raffles Medical Group (SGX:BSL) Is Doing The Right Things To Multiply Its Share Price

Here's Why Raffles Medical Group (SGX:BSL) Has Caught The Eye Of Investors

Raffles Medical Group Ltd Announces Resignation of Soo Yu-Han Jessica as Joint Company Secretary, Effective 8 August 2023

High number of new directors

First half 2023 earnings released: EPS: S$0.032 (vs S$0.032 in 1H 2022)

Raffles Medical Group Ltd Announces Appointment of Lu Liangjian as Non-Executive and Non-Independent Director

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Raffles Medical Group Ltd to Report First Half, 2023 Results on Jul 31, 2023

Raffles Medical Group (SGX:BSL) Could Easily Take On More Debt

A Look At The Fair Value Of Raffles Medical Group Ltd (SGX:BSL)

Is Now The Time To Put Raffles Medical Group (SGX:BSL) On Your Watchlist?

Upcoming dividend of S$0.038 per share at 2.6% yield

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To SGD0.038

Full year 2022 earnings: Revenues in line with analyst expectations

Raffles Medical Group (SGX:BSL) Might Have The Makings Of A Multi-Bagger

Price target increased by 8.1% to S$1.72

Full year 2022 earnings: EPS exceeds analyst expectations

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Raffles Medical Group Ltd to Report Fiscal Year 2022 Results on Feb 27, 2023

Returns At Raffles Medical Group (SGX:BSL) Are On The Way Up

Do Raffles Medical Group's (SGX:BSL) Earnings Warrant Your Attention?

Now 21% undervalued

Is There An Opportunity With Raffles Medical Group Ltd's (SGX:BSL) 25% Undervaluation?

Is Raffles Medical Group (SGX:BSL) A Risky Investment?

Now 21% undervalued

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

With EPS Growth And More, Raffles Medical Group (SGX:BSL) Makes An Interesting Case

Now 20% undervalued

Investor sentiment improved over the past week

Price target increased to S$1.52

Executive Chairman & CEO recently bought S$63k worth of stock

First half 2022 earnings released

Raffles Medical Group Ltd to Report First Half, 2022 Results on Aug 01, 2022

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Raffles Medical Group Ltd Approves Final Dividend for the Year Ended 31 December 2021

Raffles Medical Group Ltd Approves Final Dividend for the Year Ended 31 December 2021

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

Upcoming dividend of S$0.028 per share

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To S$0.028

Price target decreased to S$1.39

Raffles Medical Group Ltd Approves the Ordinary (One-Tier Tax Exempt) Core Dividend for the Financial Year Ended December 31, 2021, Payable on May 19, 2022